FI110944B - Menetelmä terapeuttisesti käyttökelpoisten pyrrolo-, pyratsolo- ja imidatso[2,1-c][1,4]diatsepiinien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten pyrrolo-, pyratsolo- ja imidatso[2,1-c][1,4]diatsepiinien valmistamiseksi Download PDF

Info

Publication number
FI110944B
FI110944B FI943543A FI943543A FI110944B FI 110944 B FI110944 B FI 110944B FI 943543 A FI943543 A FI 943543A FI 943543 A FI943543 A FI 943543A FI 110944 B FI110944 B FI 110944B
Authority
FI
Finland
Prior art keywords
pyrrolo
benzodiazepine
ylcarbonyl
phenyl
give
Prior art date
Application number
FI943543A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943543A0 (fi
FI943543A (fi
Inventor
Jay D Albright
Marvin F Reich
Fuk-Wah Sum
Efren Guillermo Delos Santos
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI943543A0 publication Critical patent/FI943543A0/fi
Publication of FI943543A publication Critical patent/FI943543A/fi
Application granted granted Critical
Publication of FI110944B publication Critical patent/FI110944B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI943543A 1993-07-29 1994-07-28 Menetelmä terapeuttisesti käyttökelpoisten pyrrolo-, pyratsolo- ja imidatso[2,1-c][1,4]diatsepiinien valmistamiseksi FI110944B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10000493A 1993-07-29 1993-07-29
US10000493 1993-07-29

Publications (3)

Publication Number Publication Date
FI943543A0 FI943543A0 (fi) 1994-07-28
FI943543A FI943543A (fi) 1995-01-30
FI110944B true FI110944B (fi) 2003-04-30

Family

ID=22277643

Family Applications (3)

Application Number Title Priority Date Filing Date
FI943543A FI110944B (fi) 1993-07-29 1994-07-28 Menetelmä terapeuttisesti käyttökelpoisten pyrrolo-, pyratsolo- ja imidatso[2,1-c][1,4]diatsepiinien valmistamiseksi
FI20011207A FI113868B (fi) 1993-07-29 2001-06-07 Menetelmä terapeuttisesti käyttökelpoisten pyrrolo [1,2-a] [1,5] bentsodiatsepiinien ja [1,2,4] triatsolo [4,3-a] [1,5] bentsodiatsepiinien valmistamiseksi
FI20011206A FI113867B (fi) 1993-07-29 2001-06-07 Menetelmä terapeuttisesti käyttökelpoisten pyrrolo [1,2-a] kinoksaliinien valmistamiseksi

Family Applications After (2)

Application Number Title Priority Date Filing Date
FI20011207A FI113868B (fi) 1993-07-29 2001-06-07 Menetelmä terapeuttisesti käyttökelpoisten pyrrolo [1,2-a] [1,5] bentsodiatsepiinien ja [1,2,4] triatsolo [4,3-a] [1,5] bentsodiatsepiinien valmistamiseksi
FI20011206A FI113867B (fi) 1993-07-29 2001-06-07 Menetelmä terapeuttisesti käyttökelpoisten pyrrolo [1,2-a] kinoksaliinien valmistamiseksi

Country Status (29)

Country Link
US (2) US5516774A (fr)
EP (1) EP0636625B1 (fr)
JP (1) JP3782475B2 (fr)
KR (1) KR100347479B1 (fr)
CN (2) CN1039908C (fr)
AT (1) ATE176234T1 (fr)
AU (1) AU683660B2 (fr)
BR (1) BR1100563A (fr)
CA (1) CA2128956C (fr)
CZ (1) CZ291322B6 (fr)
DE (1) DE69416211T2 (fr)
DK (1) DK0636625T3 (fr)
EC (1) ECSP941137A (fr)
ES (1) ES2129090T3 (fr)
FI (3) FI110944B (fr)
GR (1) GR3030069T3 (fr)
HK (1) HK1011363A1 (fr)
HU (1) HU220707B1 (fr)
IL (1) IL110435A (fr)
LV (1) LV12497B (fr)
NO (1) NO301827B1 (fr)
NZ (1) NZ264115A (fr)
PE (1) PE17895A1 (fr)
PH (1) PH31469A (fr)
PL (1) PL178563B1 (fr)
RU (1) RU2126006C1 (fr)
SG (1) SG47522A1 (fr)
SK (1) SK280836B6 (fr)
ZA (1) ZA945603B (fr)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968930A (en) * 1993-07-29 1999-10-19 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5889001A (en) * 1993-07-29 1999-03-30 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5733905A (en) * 1993-07-29 1998-03-31 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5521173A (en) * 1995-01-17 1996-05-28 American Home Products Corporation Tricyclic benzazepine vasopressin antagonists
US5536718A (en) * 1995-01-17 1996-07-16 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5753648A (en) * 1995-01-17 1998-05-19 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
AR002459A1 (es) * 1995-01-17 1998-03-25 American Cyanamid Co Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion.
US5756497A (en) * 1996-03-01 1998-05-26 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
HUP9904514A3 (en) * 1996-11-01 2000-10-30 Wyeth Corp 5h-pyrrolo[2,1-c][1,4]-benzodiazepin 3-carboxamide derivatives, process for their preparation, their use and pharmaceutical compositions containing them
US5880122A (en) * 1996-11-01 1999-03-09 American Home Products Corporation 3-Carboxamide derivatives of 5H-pyrrolo 2,1-c! 1,4!-benzodiazepines
AUPO395396A0 (en) * 1996-12-02 1997-01-02 Fujisawa Pharmaceutical Co., Ltd. Benzamide derivatives
US6511974B1 (en) 1997-07-30 2003-01-28 Wyeth Tricyclic vasopressin agonists
KR100580805B1 (ko) * 1997-07-30 2006-05-17 와이어쓰 바소프레신 효능제 활성을 갖는 트리사이클릭 화합물, 이의 제조방법 및 이를 포함하는 약제학적 조성물
US6194407B1 (en) 1997-07-30 2001-02-27 American Home Products Corporation Tricyclic pyrido vasopressin agonists
AR018818A1 (es) * 1998-04-03 2001-12-12 Yamano Masaki Una composicion farmaceutica para la terapia de un edema.
US6090803A (en) * 1998-07-24 2000-07-18 American Home Products Corporation Tricyclic vasopressin agonists
US7138393B2 (en) * 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
ATE249465T1 (de) 1999-01-19 2003-09-15 Ortho Mcneil Pharm Inc Tricyclische benzodiazepine als vasopressin antagonisten
US6344451B1 (en) 1999-02-04 2002-02-05 American Home Products Pyrrolobenzodiazepine carboxyamide vasopressin agonists
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
US6235900B1 (en) 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
US6620807B1 (en) 1999-02-04 2003-09-16 Wyeth Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
CA2358892A1 (fr) * 1999-02-04 2000-08-10 Robert John Steffan Pyrrolobenzodiazepine carboxyamide en tant qu'agonistes de la vasopressine
US6352718B1 (en) 1999-09-27 2002-03-05 American Cyanamid Company Vasopressin antagonist formulation and process
US6420358B1 (en) 1999-09-27 2002-07-16 American Cyanamid Company Vasopressin antagonist and diuretic combination
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
EA200200414A1 (ru) * 1999-09-27 2002-12-26 Американ Цианамид Компани Композиция антагониста вазопрессина и способ ее получения
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
BR0110428A (pt) * 2000-04-28 2003-06-17 Sankyo Co Composto ou um seu sal farmacologicamente aceitável, composição farmacêutica, usos de um composto ou um seu sal farmacologicamente aceitável, de um modulador de ppar gama e de um antagonista parcial, agentes que inibe a diferenciação de adipócitos, que acentua ou recupera a função osteogênica, para tratamento ou prevenção de osteoporose, que tem atividade moduladora de ppar gama, diminuidor do açúcar no sangue, para tratamento ou prevenção de diabetes melito, e, para tratamento ou prevenção
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
US7064120B2 (en) * 2001-04-12 2006-06-20 Wyeth Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
US6903091B2 (en) * 2001-04-12 2005-06-07 Wyeth Biphenyl vasopressin agonists
US6900200B2 (en) 2001-04-12 2005-05-31 Wyeth Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7202239B2 (en) * 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US7109193B2 (en) * 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
ATE375346T1 (de) * 2001-04-12 2007-10-15 Wyeth Corp Cyclohexylphenyl vasopressin agonisten
US6977254B2 (en) * 2001-04-12 2005-12-20 Wyeth Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7326700B2 (en) * 2001-04-12 2008-02-05 Wyeth Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
WO2003035602A1 (fr) * 2001-10-25 2003-05-01 Sankyo Company, Limited Modulateurs lipidiques
US7414052B2 (en) * 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US7517899B2 (en) * 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
GB0412874D0 (en) * 2004-06-09 2004-07-14 Pfizer Ltd Novel pharmaceuticals
EP1632494A1 (fr) * 2004-08-24 2006-03-08 Ferring B.V. Antagonistes de la v1a vasopressine
EP2113178A1 (fr) 2008-04-30 2009-11-04 Philip Morris Products S.A. Système de fumée chauffé électriquement avec une portion de stockage liquide
US8420633B2 (en) * 2010-03-31 2013-04-16 Hoffmann-La Roche Inc. Aryl-cyclohexyl-tetraazabenzo[e]azulenes
US8461151B2 (en) * 2010-04-13 2013-06-11 Hoffmann-La Roche Inc. Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
US8492376B2 (en) * 2010-04-21 2013-07-23 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8481528B2 (en) * 2010-04-26 2013-07-09 Hoffmann-La Roche Inc. Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
PL2587919T3 (pl) * 2010-07-01 2018-05-30 Azevan Pharmaceuticals, Inc. Sposoby leczenia zespołu stresu pourazowego
WO2012075456A1 (fr) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Inhibiteurs de bromodomaines et leurs utilisations
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US8903228B2 (en) 2011-03-09 2014-12-02 Chong Corporation Vapor delivery devices and methods
US9399110B2 (en) 2011-03-09 2016-07-26 Chong Corporation Medicant delivery system
MX356624B (es) 2011-03-09 2018-06-06 Chong Corp Sistema de entrega de medicamento.
US9422292B2 (en) 2011-05-04 2016-08-23 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9328117B2 (en) 2011-06-17 2016-05-03 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
CN107259647B (zh) 2011-09-06 2020-03-20 英美烟草(投资)有限公司 加热可点燃抽吸材料
KR101953201B1 (ko) 2011-09-06 2019-02-28 브리티시 아메리칸 토바코 (인베스트먼츠) 리미티드 가열식 흡연가능 재료
CN103288829A (zh) * 2012-02-24 2013-09-11 中国科学院大连化学物理研究所 一种合成手性二氢-5H-吡咯并[2,1-c][1,4]-苯并二氮杂卓-5-酮的方法
GB201207039D0 (en) 2012-04-23 2012-06-06 British American Tobacco Co Heating smokeable material
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
US9624244B2 (en) 2012-06-06 2017-04-18 Constellation Pharmaceuticals, Inc. Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
WO2013191041A1 (fr) * 2012-06-22 2013-12-27 住友化学株式会社 Composé amide et son utilisation pour la lutte contre les animaux nuisibles
EP2765128A1 (fr) * 2013-02-07 2014-08-13 Almirall, S.A. Benzamides substitués présentant une activité vis-à-vis de récepteurs EP4
CN103755707B (zh) * 2013-09-17 2015-11-18 天津药物研究院 利希普坦晶型ⅱ及其制备方法和用途
CN104059070B (zh) * 2013-09-17 2016-02-10 天津药物研究院有限公司 利希普坦晶型ⅰ及其制备方法和用途
CN103694240B (zh) * 2013-09-18 2015-11-18 天津药物研究院 利希普坦的溶剂合物及其制备方法和用途
CN106687463B (zh) 2014-06-20 2019-04-09 星座制药公司 一种乙酰胺类化合物的晶型
CN104140429B (zh) * 2014-07-25 2015-11-18 天津药物研究院 利希普坦晶型ⅴ及其制备方法和用途
CN104710429B (zh) * 2015-02-04 2017-02-22 浙江大学 手性螺环磷酸催化合成光学活性喹喔啉衍生物的方法
US11924930B2 (en) 2015-08-31 2024-03-05 Nicoventures Trading Limited Article for use with apparatus for heating smokable material
US20170055584A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
US20170119046A1 (en) 2015-10-30 2017-05-04 British American Tobacco (Investments) Limited Apparatus for Heating Smokable Material
BR112018010216B1 (pt) 2015-11-20 2024-02-15 Forma Therapeutics, Inc Purinonas como inibidores da protease específica da ubiquitina 1 e composição farmacêutica compreendendo os referidos compostos
CA3065910A1 (fr) * 2017-06-09 2018-12-13 Palladio Biosciences, Inc. Formulations de lixivaptan pour le traitement de la polykystose

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860600A (en) * 1972-07-10 1975-01-14 Sterling Drug Inc Octahydropyrrido{8 2,1-c{9 {8 1,4{9 benzodiazepines
DE69009785T2 (de) * 1989-02-10 1994-11-03 Otsuka Pharma Co Ltd Carbostyrilderivate.
EP0450097B1 (fr) * 1989-10-20 1996-04-24 Otsuka Pharmaceutical Co., Ltd. Composes benzoheterocycliques
TW199153B (fr) * 1990-08-07 1993-02-01 Dtsuka Seiyaku Kk
TW198715B (fr) * 1991-04-19 1993-01-21 Dtsuka Seiyaku Kk
EP0533242A3 (en) * 1991-09-16 1993-09-15 Merck & Co. Inc. Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
DE69223573D1 (de) * 1991-09-16 1998-01-29 Merck & Co Inc Hydantoin und Succinimid-substituierte Spiroindanylcamphorsulfonyl als Oxytocin-Antagonisten
US5204349A (en) * 1991-09-16 1993-04-20 Merck & Co., Inc. Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
EP0533240A3 (en) * 1991-09-16 1993-09-29 Merck & Co. Inc. Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists

Also Published As

Publication number Publication date
US5624923A (en) 1997-04-29
PL304498A1 (en) 1995-02-06
ZA945603B (en) 1995-03-09
LV12497B (lv) 2000-09-20
BR1100563A (pt) 2000-02-08
HU9402219D0 (en) 1994-09-28
LV12497A (en) 2000-06-20
EP0636625B1 (fr) 1999-01-27
FI943543A0 (fi) 1994-07-28
EP0636625A2 (fr) 1995-02-01
CZ291322B6 (cs) 2003-02-12
RU94027583A (ru) 1996-07-20
HU220707B1 (hu) 2002-04-29
ATE176234T1 (de) 1999-02-15
FI113868B (fi) 2004-06-30
EP0636625A3 (fr) 1995-05-17
KR950003295A (ko) 1995-02-16
ES2129090T3 (es) 1999-06-01
PH31469A (en) 1998-11-03
CN1205335A (zh) 1999-01-20
CN1039908C (zh) 1998-09-23
JPH07157486A (ja) 1995-06-20
FI113867B (fi) 2004-06-30
PE17895A1 (es) 1995-07-18
HK1011363A1 (en) 1999-07-09
IL110435A (en) 2003-11-23
FI20011206A (fi) 2001-06-07
DK0636625T3 (da) 1999-09-13
CA2128956C (fr) 2004-10-05
SK280836B6 (sk) 2000-08-14
CZ179994A3 (en) 1995-02-15
HUT71495A (en) 1995-11-28
AU6877794A (en) 1995-02-09
SG47522A1 (en) 1998-04-17
GR3030069T3 (en) 1999-07-30
NO301827B1 (no) 1997-12-15
IL110435A0 (en) 1994-10-21
ECSP941137A (es) 1995-02-27
JP3782475B2 (ja) 2006-06-07
RU2126006C1 (ru) 1999-02-10
KR100347479B1 (ko) 2002-12-06
CN1106812A (zh) 1995-08-16
DE69416211D1 (de) 1999-03-11
FI20011207A (fi) 2001-06-07
PL178563B1 (pl) 2000-05-31
AU683660B2 (en) 1997-11-20
NO942816D0 (no) 1994-07-28
CN1056374C (zh) 2000-09-13
DE69416211T2 (de) 1999-09-02
NO942816L (no) 1995-01-30
CA2128956A1 (fr) 1995-01-30
NZ264115A (en) 1997-10-24
US5516774A (en) 1996-05-14
FI943543A (fi) 1995-01-30
SK88194A3 (en) 1995-04-12

Similar Documents

Publication Publication Date Title
FI110944B (fi) Menetelmä terapeuttisesti käyttökelpoisten pyrrolo-, pyratsolo- ja imidatso[2,1-c][1,4]diatsepiinien valmistamiseksi
FI111077B (fi) Menetelmä terapeuttisesti käyttökelpoisten trisyklisten bentsatsepiinien valmistamiseksi
JP4163252B2 (ja) 三環式ベンゾアゼピンバソプレッシンアンタゴニスト類
FI112487B (fi) Imidatsobentso- ja -tieno[1,4]diatsepiinit
KR20070049635A (ko) Ｈｃｖ 복제 저해제
EA000056B1 (ru) Трициклические диазепины в качестве антагонистов вазопрессина, способ их получения и способ лечения с использованием трициклических диазепинов
KR20000022297A (ko) 트리사이클릭 벤즈아제핀 바소프레신 길항제
US6900200B2 (en) Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
WO1997049708A1 (fr) Les benzazepines: des antagonistes tricycliques de la vasopressine
JP5526040B2 (ja) Ｐａｒ１阻害剤としてのトリアゾロピリダジン類、その製造法および薬剤としての使用
US5885986A (en) Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments

Legal Events

Date Code Title Description
MM Patent lapsed